ERBB2 and neoplasm: We used molecular imaging to show that lovastatin increases membrane (in vitro) and tumor (in vivo) accumulation of pertuzumab (Figs. 2–4), a humanized HER2-targeted antibody that binds to the dimerization domain of HER2.